id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-D-0299-0006,FDA,FDA-2004-D-0299,FDA,Notice,NAD-Notice of Availability of Data,2007-07-30T04:00:00Z,2007,7,,,2008-04-12T00:35:40Z,,0,0,0900006480472d3e
FDA-2004-D-0299-0007,FDA,FDA-2004-D-0299,Guidance,Supporting & Related Material,GDL-Guidance,2007-07-30T04:00:00Z,2007,7,,,2008-04-12T00:35:40Z,,0,0,0900006480472d3f
FDA-2004-D-0299-0004,FDA,FDA-2004-D-0299,FDA,Notice,NAL-Notice of Approval,2006-10-25T04:00:00Z,2006,10,2006-10-23T04:00:00Z,,2008-04-12T00:35:41Z,,0,0,0900006480472d3c
FDA-2004-D-0299-0005,FDA,FDA-2004-D-0299,Supporting Statement,Supporting & Related Material,SS-Supporting Statement,2006-10-25T04:00:00Z,2006,10,,,2008-04-12T00:35:40Z,,0,0,0900006480472d3d
FDA-2004-D-0299-0003,FDA,FDA-2004-D-0299,FDA,Notice,N-Notice,2006-07-18T04:00:00Z,2006,7,2006-07-17T04:00:00Z,,2008-04-12T00:35:41Z,,0,0,0900006480472d3b
FDA-2004-D-0299-0001,FDA,FDA-2004-D-0299,FDA,Notice,NAD-Notice of Availability of Data,2005-07-06T04:00:00Z,2005,7,2005-07-05T04:00:00Z,2005-09-07T03:59:59Z,2008-04-12T00:35:41Z,,0,0,0900006480472d2a
FDA-2004-D-0299-0002,FDA,FDA-2004-D-0299,Guidance,Supporting & Related Material,GDL-Guidance,2005-07-05T04:00:00Z,2005,7,,,2008-04-12T00:35:40Z,,0,0,0900006480472d2d